retatrutide side effects clinical trial results 2024 2025 More data on dropped today at the ADA conference!! Reta is an investigational -not FDA approved yet- once-weekly medication that simultaneously activates the GIP, GLP-1, and glucagon receptors In the Phase Triple Agonism Based Therapies for

271,272 In one randomized controlled trial, 84 postmenopausal women experiencing at least two moderate-to-severe hot flashes daily were assigned to eat a low-fat vegan diet (that included cooked soybeans) or make no dietary change

All PlexusDx compounds are sourced exclusively from 503A facilities

GLP-1 medications offer meaningful health benefits, but this survey highlights trends related to cost and insurance coverage that introduce uncertainty for a patients ability to access these drugs, said Sharon Faust, Chief Pharmacy Officer at Navitus Health Solutions

I am not sure what the cause is for that

Timing: Administered before meals or before bedtime

Online confirmed that in June 2025, during an appearance on the Just Trish podcast, Lizzo admitted she had tried Ozempic and other GLP-1 drugs before deciding the method wasnt effective for her goals